Ngā hua rapu - Hiroto Inaba

Whakamahine hua
  1. 1
    Childhood acute myeloid leukaemia

    Childhood acute myeloid leukaemia mā Jeffrey E. Rubnitz, Hiroto Inaba

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Glucocorticoid use in acute lymphoblastic leukaemia

    Glucocorticoid use in acute lymphoblastic leukaemia mā Hiroto Inaba, Ching‐Hon Pui

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Immunotherapy in pediatric acute lymphoblastic leukemia

    Immunotherapy in pediatric acute lymphoblastic leukemia mā Hiroto Inaba, Ching‐Hon Pui

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Pediatric acute lymphoblastic leukemia

    Pediatric acute lymphoblastic leukemia mā Hiroto Inaba, Charles G. Mullighan

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia

    Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia mā Hiroto Inaba, Ching‐Hon Pui

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Acute lymphoblastic leukaemia

    Acute lymphoblastic leukaemia mā Hiroto Inaba, Mel Greaves, Charles G. Mullighan

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Integration of Next-Generation Sequencing to Treat Acute Lymphoblastic Leukemia with Targetable Lesions: The St. Jude Children’s Research Hospital Approach

    Integration of Next-Generation Sequencing to Treat Acute Lymphoblastic Leukemia with Targetable Lesions: The St. Jude Children’s Research Hospital Approach mā Hiroto Inaba, Elizabeth M. Azzato, Charles G. Mullighan

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia

    NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia mā Jeffrey E. Rubnitz, Hiroto Inaba, Raul C. Ribeiro, Stanley Pounds, Barbara Rooney, Teresa M. Bell, Ching‐Hon Pui, Wing Leung

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Decreased relapsed rate and treatment‐related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials

    Decreased relapsed rate and treatment‐related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials mā Thomas Alexander, Lei Wang, Hiroto Inaba, Brandon M. Triplett, Stanley Pounds, Raul C. Ribeiro, Ching‐Hon Pui, Jeffrey E. Rubnitz

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis

    Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis mā Hiroto Inaba, Ying Fan, Stanley Pounds, Terrence L. Geiger, Jeffrey E. Rubnitz, Raul C. Ribeiro, Ching‐Hon Pui, Bassem I. Razzouk

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation

    Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation mā Hiroto Inaba, Jie Yang, Jianmin Pan, Dennis C. Stokes, Matthew J. Krasin, Ashok Srinivasan, Christine Hartford, Ching‐Hon Pui, Wing Leung

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Longitudinal Changes in Body Mass and Composition in Survivors of Childhood Hematologic Malignancies After Allogeneic Hematopoietic Stem-Cell Transplantation

    Longitudinal Changes in Body Mass and Composition in Survivors of Childhood Hematologic Malignancies After Allogeneic Hematopoietic Stem-Cell Transplantation mā Hiroto Inaba, Jie Yang, Sue C. Kaste, Christine Hartford, Megan S. Motosue, Wassim Chemaitilly, Brandon M. Triplett, David Shook, Ching‐Hon Pui, Wing Leung

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia

    Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia mā Emily Browne, Yinmei Zhou, Wassim Chemaitilly, John C. Panetta, Kirsten K. Ness, Sue C. Kaste, Cheng Cheng, Mary V. Relling, Ching‐Hon Pui, Hiroto Inaba

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51

    Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51 mā Chengzhi Xie, Christina D. Drenberg, Holly Edwards, J. Timothy Caldwell, Wei Chen, Hiroto Inaba, Xuelian Xu, Steven Buck, Jeffrey W. Taub, Sharyn D. Baker, Yubin Ge

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Natural killer cell therapy in children with relapsed leukemia

    Natural killer cell therapy in children with relapsed leukemia mā Jeffrey E. Rubnitz, Hiroto Inaba, Guolian Kang, Kwan Gan, Christine Hartford, Brandon M. Triplett, Mari Dallas, David Shook, Tanja A. Grüber, Ching‐Hon Pui, Wing Leung

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia

    Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia mā Joshua Wolf, Li Tang, Patricia M. Flynn, Ching‐Hon Pui, Aditya H. Gaur, Yilun Sun, Hiroto Inaba, Tracy B. Stewart, Randall T. Hayden, Hana Hakim, Sima Jeha

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Crenolanib is active against models of drug-resistant FLT3-ITD−positive acute myeloid leukemia

    Crenolanib is active against models of drug-resistant FLT3-ITD−positive acute myeloid leukemia mā Eric I. Zimmerman, David C. Turner, Jassada Buaboonnam, Shuiying Hu, Shelley Orwick, Michael S. Roberts, Laura J. Janke, Abhijit Ramachandran, Clinton F. Stewart, Hiroto Inaba, Sharyn D. Baker

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia

    The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia mā Takaya Moriyama, Rina Nishii, Ting-Nien Lin, Kentaro Kihira, Hidemi Toyoda, Jacob Nersting, Motohiro Kato, Katsuyoshi Koh, Hiroto Inaba, Atsushi Manabe, Kjeld Schmiegelow, Jun J. Yang, Hiroki Hori

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Peripheral neuropathy in children and adolescents treated for cancer

    Peripheral neuropathy in children and adolescents treated for cancer mā Kari Bjornard, Laura Gilchrist, Hiroto Inaba, B Diouf, Marilyn Hockenberry, Nina S. Kadan‐Lottick, Daniel C. Bowers, M. Eileen Dolan, Nicole J. Ullrich, William E. Evans, Kirsten K. Ness

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia

    Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia mā Hiroto Inaba, Aditya H. Gaur, Xueyuan Cao, Patricia M. Flynn, Stanley Pounds, Viswatej Avutu, Lindsay N. Marszal, Scott C. Howard, Ching‐Hon Pui, Raul C. Ribeiro, Randall T. Hayden, Jeffrey E. Rubnitz

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: